Prevalence of daily medication adherence among children with sickle cell disease: a 1-year retrospective cohort analysis.

Pediatric Blood & Cancer
Niti G PatelMichael R DeBaun

Abstract

The objective of this study is to determine the prevalence of adherence to daily medications among children with sickle cell disease (SCD). Prescription records for 12 months were obtained from participants who had insurance in a Medicaid-based single health maintenance organization. Adherence was measured as a ratio between the number of expected days and the observed days between two refill periods for daily medications. A total of 93 children were studied. The average refill prescription rate was 58.4%. More formal strategies are required to identify barriers to prescription refills among children with SCD.

References

Nov 1, 1995·Journal of Psychosomatic Research·F S WamboldtS M Brugman
Nov 3, 1998·American Journal of Hematology·F P van der DijsF A Muskiet
Apr 26, 2000·Journal of Clinical and Experimental Neuropsychology·D A WhiteM DeBaun
Aug 5, 2004·Psychiatric Services : a Journal of the American Psychiatric Association·Peter J WeidenJulie Locklear
Nov 6, 2004·Journal of Clinical Epidemiology·Robert GrossbergRobert Gross
Mar 4, 2006·Pharmacoepidemiology and Drug Safety·Susan E AndradeK Arnold Chan
Nov 28, 2006·Pediatric Clinics of North America·Eran KozerGideon Koren
Jul 26, 2007·Haematologica·Jessica H BoydMichael R DeBaun
Mar 28, 2008·The New England Journal of Medicine·Orah S Platt
Apr 18, 2008·Journal of Medical Screening·Allison StreetlyJoan Henthorn
Jan 17, 2009·Pediatric Blood & Cancer·Jean L RaphaelBrigitta U Mueller
Feb 3, 2009·Journal of Psychiatric Practice·Rose J JuliusWilliam R Dubin
Feb 4, 2009·International Journal of Nursing Practice·Elaine Lehane, Geraldine McCarthy
Feb 21, 2009·American Journal of Hematology·Claudia R Morris
Nov 3, 2009·The Journal of Pediatrics·Courtney D ThornburgAlex R Kemper

❮ Previous
Next ❯

Citations

Nov 9, 2010·Pediatric Blood & Cancer·Brigitta U Mueller
Apr 23, 2014·Pediatric Blood & Cancer·ElShadey BekeleNancy S Green
Apr 30, 2014·American Journal of Hematology·Lauren M BeverungJulie A Panepinto
Sep 20, 2015·Journal of Pediatric Psychology·Kristin LoiselleAhna L H Pai
Mar 8, 2016·Journal of Pediatric Hematology/oncology·David G BundyMarlene R Miller
Aug 18, 2009·BMC Blood Disorders·Thelma K Toni-Uebari, Baba P D Inusa
Aug 30, 2016·Journal of Pediatric Hematology/oncology·Giang-Kim T NguyenElizabeth Yang
Nov 10, 2018·Journal of Paediatrics and Child Health·Chung-Jen ChenNancy S Green
Mar 20, 2020·Pediatric Quality & Safety·Christopher McKinneyRachelle Nuss
May 23, 2020·JMIR Research Protocols·Jane S HankinsUNKNOWN Sickle Cell Disease Implementation Consortium
Apr 4, 2019·Pediatric Blood & Cancer·Marianne E McPherson YeeAngela G Brega
May 23, 2019·Clinical Pediatrics·Sarah L ReevesKevin J Dombkowski
Dec 5, 2019·Journal of Medical Internet Research·Lakshmanan KrishnamurtiGeorge Loewenstein

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.